Parameter | Athletes (n = 134) | Control population (n = 110) | P value |
---|---|---|---|
M/F (n) | 77/57 | 80/30 | |
Age (years) | 23.2 ± 5 | 40 ± 11 | < 0.05 |
C3 (mg/dL, normal range: 0.9–1.8) | 0.96 ± 0.1 | 1.08 ± 0.2 | < 0.001 |
C3 deficiency (%) | 31.3 | 14.5 | < 0.005 |
C4 (mg/dL, normal range: 0.1–0.4) | 0.18 ± 0.1 | 0.25 ± 0.1 | < 0.001 |
C4 deficiency (%) | 6.0 | 0 | < 0.05 |
MBL (μg/L, normal range: 103–3308) | 1141 ± 820 | 792 ± 590 | < 0.001 |
Classical pathway activation (%, normal range: 66–100) | 82.2 ± 15 | 93.9 ± 10 | < 0.001 |
Classical pathway deficiency (%) | 14.4 | 2.8 | < 0.05 |
Alternative pathway activation (%, normal range: 25–100) | 68.3 ± 20 | 78.1 ± 14 | < 0.001 |
Alternative pathway deficiency (%) | 4.8 | 0 | < 0.05 |
Lectin pathway activation (%, normal range: 10–100) | 44.3 ± 39 | 33.4 ± 34 | NS |
Lectin pathway deficiency (%) | 27.9 | 34.9 | NS |